Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GeneFerm Biotechnology CoROCO:1796 -1.26%65 Dividend Yield % is 2.20% as of Jul. 20, 2026, which is 3% below its 10-year median of 2.27. GuruFocus rates ROCO:1796 with a GF Score™ of 65/100 and a GF Value™ of NT$59.04 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 513 Drug Manufacturers companies, GeneFerm Biotechnology Co ranks better than 54.97% on this metric.
During the past 12 months, GeneFerm Biotechnology Co's average Dividends Per Share Growth Rate was -100.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GeneFerm Biotechnology Co was 188.80% per year. The lowest was -56.40% per year. And the median was 26.10% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
GeneFerm Biotechnology Co (ROCO:1796) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1796 vs ZTS, UTHR: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, GeneFerm Biotechnology Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GeneFerm Biotechnology Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GeneFerm Biotechnology Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where GeneFerm Biotechnology Co's Dividend Yield % falls into.
GeneFerm Biotechnology Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
GeneFerm Biotechnology Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 0.700000
2026-07-14
2026-07-15
2026-07-30
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GeneFerm Biotechnology Co (ROCO:1796) has a Dividend Yield % of 2.20% as of Jul. 20, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on GeneFerm Biotechnology Co and its competitors. This is near median its historical median of 2.27. Over the past decade, GeneFerm Biotechnology Co's Dividend Yield % has ranged from 0.18 to 7.38. According to the industry distribution chart, GeneFerm Biotechnology Co ranks #231 out of 513 companies in the Drug Manufacturers industry, placing it in the top 45%.
Is GeneFerm Biotechnology Co's Dividend Yield % too high?
GeneFerm Biotechnology Co's current Dividend Yield % of 2.20% is near median its 10-year median of 2.27. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 7.38. The Drug Manufacturers industry median Dividend Yield % is 1.92. GeneFerm Biotechnology Co's value of 2.20% is 14.6% above this industry median. Based on the distribution chart, GeneFerm Biotechnology Co ranks #231 out of 513 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, GeneFerm Biotechnology Co has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GeneFerm Biotechnology Co's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, GeneFerm Biotechnology Co ranks #231 out of 513 companies for Dividend Yield %. This puts GeneFerm Biotechnology Co in the upper half of its industry. The industry median Dividend Yield % is 1.92. GeneFerm Biotechnology Co's value of 2.20% is 14.6% above this benchmark. Historically, GeneFerm Biotechnology Co's own Dividend Yield % has ranged from 0.18 to 7.38 over the past decade. While the company's 10-year median is 2.27 vs. the industry median of 1.92, GeneFerm Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.92, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GeneFerm Biotechnology Co's current Dividend Yield % of 2.20% is 14.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on GeneFerm Biotechnology Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GeneFerm Biotechnology Co's current Dividend Yield % is 2.20%, which is near median its own 10-year median of 2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GeneFerm Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, GeneFerm Biotechnology Co (ROCO:1796) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$59.04, compared to a current price of NT$31.40 — trading 46.8% below its estimated fair value. The current Dividend Yield % is 2.20%, which is near median its 10-year median of 2.27 and 14.6% above the Drug Manufacturers industry median of 1.92. GeneFerm Biotechnology Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For GeneFerm Biotechnology Co (ROCO:1796), the current Dividend Yield % is 2.20% as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GeneFerm Biotechnology Co (ROCO:1796) Overvalued in 2026?
Based on GuruFocus' analysis, GeneFerm Biotechnology Co stock appears to be undervalued.
The current stock price of NT$31.40 is trading 46.8% below its estimated GF Value™ of NT$59.04.
GuruFocus considers GeneFerm Biotechnology Co to be Significantly Undervalued.
Key valuation signals for ROCO:1796:
Dividend Yield %: 2.20% (near median its 10-year median of 2.27)
GF Value™: NT$59.04 vs. price of NT$31.40 (46.8% below fair value)
Industry Position: 14.6% above the Drug Manufacturers median (#231 of 513)
No single metric tells the full story. See the ROCO:1796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GeneFerm Biotechnology Co Ltd is a fermentation company based in Taiwan. It is engaged in manufacturing health food and supplements which include Fermented Microbial products, Fermented Fungi products, Probiotics and Extraction, and Concentration products among others.
65GF Score
Get the complete analysis for ROCO:1796
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1796 has been successfully added to your 
